STABILITY-INDICATING RP-HPLC METHOD FOR ANALYSIS OF ATORVASTATIN IN BULK DRUG, MARKETED TABLET AND NANOEMULSION FORMULATION

被引：0

作者：

Mustafa, Gulam ^{[1
]}

Azeem, Adnan ^{[1
]}

Ahmad, Farhan J. ^{[1
]}

Khan, Zeenat I. ^{[1
]}

Shakeel, Faiyaz ^{[2
]}

Talegaonkar, Sushma ^{[1
]}

机构：

[1] Fac Pharm, Dept Pharmaceut, New Delhi 110062, India

[2] Al Arab Med Univ, Fac Pharm, Dept Pharmaceut, Benghazi, Libya

来源：

JOURNAL OF THE CHILEAN CHEMICAL SOCIETY | 2010年 / 55卷 / 02期

关键词：

RP-HPLC; atorvastatin; nanoemulsion; tablets; ICH guidelines; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; HUMAN SERUM; VALIDATION; ASSAY; UV; QUANTITATION; AMLODIPINE; CALCIUM;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A simple, highly sensitive, isocratic stability indicating reversed phase-high performance liquid chromatography (RP-HPLC) method with UV detection at 247 nm was developed and validated for analysis of atorvastatin (AT). Retention time of the AT was found to be 4.02 min. A mobile phase consisting of 0.05 M sodium phosphate buffer and methanol (3:7 v/v) pH 4.1 at flow rate of 1 mL/min was employed in this study. The calibration curves were linear with regression coefficient (r(2)) of 0.9997 +/- 0.0014. The limits of detection (LOD) and the limits of quantification (LOQ) were found to be 0.20 and 0.60 mu g/mL, respectively. The method was statistically validated in accordance with International conference on harmonization (ICH) guidelines. The proposed method was found sensitive, specific and was successfully applied for the estimation of atorvastatin in pharmaceutical formulations (bulk drug, tablet, nanoemulsion).

引用

页码：184 / 188

页数：5

共 32 条

[21] Development and bioavailability assessment of ramipril nanoemulsion formulation
Shafiq, Sheikh
Shakeel, Faiyaz
Talegaonkar, Sushma
Ahmad, Farhan J.
Khar, Roop K.
Ali, Mushir
[J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 66 (02) : 227 - 243
[22] Shah D. A., 2007, Indian Journal of Pharmaceutical Sciences, V69, P546
[23] Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation products
Shah, Ravi P.
Kumar, Vijay
Singh, Saranjit
[J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2008, 22 (05) : 613 - 622
[24] Shakeel F, 2008, J DRUG TARGET, V16, P733, DOI [10.1080/10611860802473402, 10.1080/10611860802473402 ]
[25] Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion
Shakeel F.
Baboota S.
Ahuja A.
Ali J.
Shafiq S.
[J]. Journal of Nanobiotechnology, 6 (1)
[26] Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin
Shen, HaiRong
Zhong, MingKang
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (09) : 1183 - 1191
[27] Shen HR, 2006, PHARMAZIE, V61, P18
[28] An improved HPLC method with the aid of a chemometric protocol: Simultaneous analysis of amiodipine and atorvastatin in pharmaceutical formulations
Sivakumar, Thanikachalam
Manavalan, Rajappan
Muralidharan, Chandrasekharan
Valliappan, Kannappan
[J]. JOURNAL OF SEPARATION SCIENCE, 2007, 30 (18) : 3143 - 3153
[29] Stanisz Beata, 2006, Acta Pol Pharm, V63, P471
[30] Yadav SS., 2005, Indian J Pharm Sci, V67, P182

← 1 2 3 4 →